David H Collier
Overview
Explore the profile of David H Collier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
2676
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pappas D, OBrien J, Guo L, Shan Y, Baker J, Kricorian G, et al.
Arthritis Res Ther
. 2023 Sep;
25(1):166.
PMID: 37689684
Background: Real-world studies assessing the comparative effectiveness of biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) as first-line targeted therapy are scarce. We analyzed the real-world persistence and effectiveness of...
2.
Mease P, OBrien J, Middaugh N, Kricorian G, Stryker S, Collier D, et al.
ACR Open Rheumatol
. 2023 Jun;
5(8):388-398.
PMID: 37356824
Objective: Real-world studies assessing treatment response by psoriatic arthritis (PsA) domains are limited. This study aimed to describe the patient characteristics, frequency and combinations of disease domains, disease activity, and...
3.
Curtis J, Emery P, Kricorian G, Yen P, Collier D, Bykerk V, et al.
J Rheumatol
. 2023 Apr;
50(9):1114-1120.
PMID: 37061234
Objective: Some patients with rheumatoid arthritis (RA) who persist in remission may decide to stop their therapy. We evaluated baseline characteristics associated with remaining in remission or low disease activity...
4.
Curtis J, Stolshek B, Emery P, Haraoui B, Karis E, Kricorian G, et al.
J Clin Rheumatol
. 2022 Dec;
29(1):16-22.
PMID: 36459119
Background/objective: The effect of treatment withdrawal on patient-reported outcomes (PROs) in patients with rheumatoid arthritis (RA) whose disease is in sustained remission has not been well described. This analysis aimed...
5.
Mease P, Gladman D, Merola J, Deodhar A, Ogdie A, Collier D, et al.
J Rheumatol
. 2022 Apr;
49(8):885-893.
PMID: 35428718
Objective: In this post hoc analysis, we examined the potential impact of sex and BMI on response in the Study of Etanercept and Methotrexate in Combination or as Monotherapy in...
6.
Mease P, Stryker S, Liu M, Salim B, Rebello S, Gharaibeh M, et al.
Arthritis Res Ther
. 2021 Sep;
23(1):236.
PMID: 34496952
Background: Understanding the evolving treatment patterns in patients with rheumatoid arthritis (RA) is important for rheumatologists to make the best practice decisions and optimize treatment. Here, we describe treatment patterns...
7.
Holdsworth E, Donaghy B, Fox K, Desai P, Collier D, Furst D
Rheumatol Ther
. 2021 Sep;
8(4):1637-1649.
PMID: 34487340
Introduction: In patients with inadequate response or intolerance to first biologic disease-modifying antirheumatic drug (bDMARD), guidelines recommend switching to an agent of different mechanism of action or to another bDMARD....
8.
Strand V, Mease P, Maksabedian Hernandez E, Stolshek B, Liu L, Collier D, et al.
RMD Open
. 2021 Jan;
7(1).
PMID: 33452180
Objectives: We examined patient-reported outcomes (PROs) in The Study of Etanercept And Methotrexate in Patients with Psoriatic Arthritis (PsA); a 48-week, phase 3, randomised controlled trial that compared outcomes with...
9.
Rumsey D, Lougee A, Matsouaka R, Collier D, Schanberg L, Schenfeld J, et al.
Arthritis Care Res (Hoboken)
. 2020 Dec;
73(7):940-946.
PMID: 33331139
Objective: To describe characteristics of children with enthesitis-related arthritis (ERA) and juvenile psoriatic arthritis (PsA) who were enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry. Methods: All...
10.
Sauer B, Chen W, Xu Y, Shen J, Accortt N, Collier D, et al.
Arthritis Res Ther
. 2020 Oct;
22(1):253.
PMID: 33092642
Background: A previous analysis of the Veterans Affairs Rheumatoid Arthritis (VARA) registry showed that more than half of the patients with rheumatoid arthritis (RA) did not receive a major therapeutic...